Thymocyte Differentiation is Regulated by a Change in Estradiol Levels during the Estrous Cycle in Mouse
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Recent study showed that T cells in the immune organs and peripheral blood are influenced by estradiol, leading to a dysfunction of the immune system. However, little is known about the thymic-gonadal relationship during the estrous cycle in mouse. Therefore, the purpose of this study was to elucidate the mechanism by which a change in estradiol levels during the estrous cycle regulates the development of T cells in the mouse thymus. Six-week-old ICR mice were used and divided into four groups, including diestrous, proestrous, estrous, and metestrous. We first confirmed that ER-α and - β estrogen receptors were expressed in thymic epithelial cells, showing that their expression was not different during the estrous cycle. There was also no significant difference in thymic weight and total number of thymocytes during the estrous cycle. To determine the degree of thymocyte differentiation during the estrous cycle, we analyzed thymocytes by flow cytometry. As a result, the percentage of CD4+CD8+ double-positive (DP) T cells was significantly decreased in the proestrous phase compared to the diestrous phase. However, CD4+CD8- or CD4-CD8+ (SP) T cells were significantly increased in the proestrous phase compared to the diestrous phase. In addition, the percentage of CD44+CD25- (DN1) T cells was significantly decreased in the estrous phase compared to other phases, whereas the percentages of CD44+CD25+ (DN2), CD44-CD25+ (DN3), and CD44-CD25- (DN4) were not changed during the estrous cycle. These results indicate that the development of thymocytes may arrest in the DP to SP transition stage in the proestrous phase displaying the highest serum level of estradiol. This study suggests that a change in estradiol levels during the estrous cycle may be involved in the regulation of thymocyte differentiation in the mouse thymus.
Abstract
Recent study showed that T cells in the immune organs and peripheral blood are influenced by estradiol, leading to a dysfunction of the immune system. However, little is known about the thymic-gonadal relationship during the estrous cycle in mouse. Therefore, the purpose of this study was to elucidate the mechanism by which a change in estradiol levels during the estrous cycle regulates the development of T cells in the mouse thymus. Six-week-old ICR mice were used and divided into four groups, including diestrous, proestrous, estrous, and metestrous. We first confirmed that ER-α and - β estrogen receptors were expressed in thymic epithelial cells, showing that their expression was not different during the estrous cycle. There was also no significant difference in thymic weight and total number of thymocytes during the estrous cycle. To determine the degree of thymocyte differentiation during the estrous cycle, we analyzed thymocytes by flow cytometry. As a result, the percentage of CD4+CD8+ double-positive (DP) T cells was significantly decreased in the proestrous phase compared to the diestrous phase. However, CD4+CD8- or CD4-CD8+ (SP) T cells were significantly increased in the proestrous phase compared to the diestrous phase. In addition, the percentage of CD44+CD25- (DN1) T cells was significantly decreased in the estrous phase compared to other phases, whereas the percentages of CD44+CD25+ (DN2), CD44-CD25+ (DN3), and CD44-CD25- (DN4) were not changed during the estrous cycle. These results indicate that the development of thymocytes may arrest in the DP to SP transition stage in the proestrous phase displaying the highest serum level of estradiol. This study suggests that a change in estradiol levels during the estrous cycle may be involved in the regulation of thymocyte differentiation in the mouse thymus.
참고문헌 (35)
- Anderson G, "Lymphostromal interactions in thymic development and function", Nat Rev Immunol, 1, pp.31~40 (2001)
- Anderson G, "Establishment and functioning of intrathymic microenvironments", Immunol Rev, 209, pp.10~27 (2006)
- Boyd RL, "The thymic microenvironment", Immunol Today, 14, pp.445~459 (1993)
- Brunelli R, "Changes in thymocyte subsets induced by estradiol administration or pregnancy", Ann N Y Acad Sci, 650, pp.109~114 (1992)
- Chidgey A, "Impact of niche aging on thymic regeneration and immune reconstitution", Semin Immunol, 19, pp.331~340 (2007)
- Clarke AG, "The thymus in pregnancy: the interplay of neural, endocrine and immune influences", Immunol Today, 15, pp.545~551 (1994)
- Couse JF, "Estrogen receptor null mice: what have we learned and where will they lead us?", Endocr Rev, 20, pp.358~417 (1999)
- Dardenne M, "Interdependence of the endocrine and immune systems", Adv Neuroimmunol, 6, pp.297~307 (1996)
- Di Santo JP, "In vivo roles of receptor tyrosine kinases and cytokine receptors in early thymocyte development", Curr Opin Immunol, 10, pp.196~207 (1998)
- Do Y, "Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo", Toxicol Sci, 70, pp.63~72 (2002)
- Erlandsson MC, "Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus", Immunology, 103, pp.17~25 (2001)
- Fabris N, "Plasticity of neuro-endocrine-thymus interactions during aging--a minireview", Cell Mol Biol (Noisy-le-grand), 43, pp.529~541 (1997)
- Holladay SD, "Selective prothymocyte targeting by prenatal diethylstilbesterol exposure", Cell Immunol, 152, pp.131~142 (1993)
- Holub M, "Thymus rudiment of the athymic nude mouse", Nature, 256, pp.491~493 (1975)
- Jenkinson WE, "An epithelial progenitor pool regulates thymus growth", J Immunol, 181, pp.6101~6108 (2008)
- Jenkinson WE, "PDGFRalpha-expressing mesenchyme regulates thymus growth and the availability of intrathymic niches", Blood, 109, pp.954~960 (2007)
- Kawashima I, "Localization of estrogen receptors and estrogen receptor-mRNA in female mouse thymus", Thymus, 20, pp.115~121 (1992)
- Kuiper GG, "Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta", Endocrinology, 138, pp.863~870 (1997)
- Luster MI, "Estrogen immunosuppression is regulated through estrogenic responses in the thymus", J Immunol, 133, pp.110~116 (1984)
- Malek TR, "Multiple gamma c-dependent cytokines regulate T-cell development", Immunol Today, 20, pp.71~76 (1999)
- Mocchegiani E, "Plasticity of neuroendocrine-thymus interactions during ontogeny and ageing: role of zinc and arginine", Ageing Res Rev, 5, pp.281~309 (2006)
- Mor G, "The role of the Fas", Fas ligand system in estrogen-induced thymic alteration, 2001, pp.46, 298~307
- Okasha SA, "Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus", Toxicology, 163, pp.49~62 (2001)
- Petrie HT, "Cell migration and the control of postnatal T-cell lymphopoiesis in the thymus", Nat Rev Immunol, 3, pp.859~866 (2003)
- Revest JM, "Development of the thymus requires signaling through the fibroblast growth factor receptor R2-IIIb", J Immunol, 167, pp.1954~1961 (2001)
- Rijhsinghani AG, "Estrogen blocks early T cell development in the thymus", Am J Reprod Immunol, 36, pp.269~277 (1996)
- Ritter MA, "Development in the thymus: it takes two to tango", Immunol Today, 14, pp.462~469 (1993)
- Screpanti I, "Steroid sensitivity of thymocyte subpopulations during intrathymic differentiation. Effects of 17 beta-estradiol and dexamethasone on subsets expressing T cell antigen receptor or IL-2 receptor", J Immunol, 142, pp.3378~3383 (1989)
- Silverstone AE, "Dexamethasone, beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets", Toxicol Appl Pharmacol, 126, pp.248~259 (1994)
- Staples JE, "Estrogen receptor alpha is necessary in thymic development and estradiol-induced thymic alterations", J Immunol, 163, pp.4168~4174 (1999)
- Takahama Y, "Journey through the thymus: stromal guides for T-cell development and selection", Nat Rev Immunol, 6, pp.127~135 (2006)
- Thyagarajan S, "Modulation of neuroendocrine--immune signaling by L-deprenyl and Ldesmethyldeprenyl in aging and mammary cancer", Mech Ageing Dev, 123, pp.1065~1079 (2002)
- Wang C, "GPR30 contributes to estrogen-induced thymic atrophy", Mol Endocrinol, 22, pp.636~648 (2008)
- Yao G, "Thymic atrophy via estrogen-induced apoptosis is related to Fas", FasL pathway, 2004, pp.4, 213~221
- Yellayi S, "The phytoestrogen genistein induces thymic and immune changes: a human health concern?", Proc Natl Acad Sci U S A, 99, pp.7616~7621 (2002)
